Virtu Financial’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,986
| Closed | -$931K | – | 1449 |
|
|
2025
Q1 | $931K | Buy |
+7,986
| New | +$931K | 0.05% | 296 |
|
|
2023
Q4 | – | Sell |
-13,686
| Closed | -$956K | – | 1565 |
|
|
2023
Q3 | $956K | Sell |
13,686
-15,893
| -54% | -$1.11M | 0.1% | 185 |
|
|
2023
Q2 | $2.13M | Buy |
29,579
+23,508
| +387% | +$1.69M | 0.16% | 99 |
|
|
2023
Q1 | $374K | Buy |
+6,071
| New | +$374K | 0.04% | 450 |
|
|
2022
Q4 | – | Sell |
-9,466
| Closed | -$422K | – | 1595 |
|
|
2022
Q3 | $422K | Buy |
9,466
+1,111
| +13% | +$49.5K | 0.04% | 475 |
|
|
2022
Q2 | $320K | Buy |
+8,355
| New | +$320K | 0.03% | 553 |
|
|
2021
Q4 | – | Sell |
-20,292
| Closed | -$669K | – | 1706 |
|
|
2021
Q3 | $669K | Buy |
+20,292
| New | +$669K | 0.06% | 343 |
|
|
2021
Q2 | – | Sell |
-5,940
| Closed | -$336K | – | 1509 |
|
|
2021
Q1 | $336K | Buy |
+5,940
| New | +$336K | 0.02% | 749 |
|
|
2020
Q4 | – | Sell |
-12,320
| Closed | -$878K | – | 1428 |
|
|
2020
Q3 | $878K | Buy |
12,320
+6,336
| +106% | +$452K | 0.15% | 147 |
|
|
2020
Q2 | $492K | Buy |
+5,984
| New | +$492K | 0.06% | 380 |
|
|
2018
Q3 | – | Sell |
-18,609
| Closed | -$60K | – | 1527 |
|
|
2018
Q2 | $60K | Buy |
+18,609
| New | +$60K | ﹤0.01% | 1723 |
|